BRAWNPharmaceuticals
Brawn Biotech Ltd — Cash Flow Statement
₹20.85
-0.71%
Brawn Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -0.19 Cr | -0.04 Cr | 0.22 Cr | -0.11 Cr | — |
| Capital Expenditure | -0.24 Cr | -0.01 Cr | -0.10 Cr | -0.30 Cr | — |
| End Cash Position | -0.19 Cr | 0.41 Cr | 0.44 Cr | 0.22 Cr | — |
| Beginning Cash Position | 40000.00 | 0.44 Cr | 0.22 Cr | 0.40 Cr | — |
| Changes In Cash | -0.20 Cr | -0.04 Cr | 0.21 Cr | -0.17 Cr | — |
| Financing Cash Flow | -37000.00 | -38000.00 | -82270.00 | -0.06 Cr | — |
| Interest Paid Cff | -37000.00 | -38000.00 | -82270.00 | -0.06 Cr | — |
| Investing Cash Flow | -0.24 Cr | -0.01 Cr | -0.10 Cr | -0.30 Cr | — |
| Capital Expenditure Reported | -0.24 Cr | -0.01 Cr | -0.10 Cr | -0.30 Cr | — |
| Operating Cash Flow | 0.05 Cr | -0.03 Cr | 0.32 Cr | 0.19 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 80300.00 | 0.00 | — |
| Change In Working Capital | 1.69 Cr | 1.46 Cr | 0.65 Cr | 2.12 Cr | — |
| Change In Other Current Liabilities | 0.26 Cr | -0.75 Cr | 0.02 Cr | 0.03 Cr | — |
| Change In Payable | 7.38 Cr | 2.03 Cr | 1.63 Cr | 1.51 Cr | — |
| Change In Inventory | -4.45 Cr | -1.23 Cr | -0.07 Cr | -4.47 Cr | — |
| Change In Receivables | -1.56 Cr | 1.38 Cr | -0.94 Cr | 5.10 Cr | — |
| Other Non Cash Items | 36000.00 | 37000.00 | 82270.00 | 0.06 Cr | — |
| Depreciation And Amortization | 0.11 Cr | 0.05 Cr | 0.11 Cr | 0.05 Cr | — |
| Depreciation | 0.11 Cr | 0.05 Cr | 0.11 Cr | 0.05 Cr | — |
| Pension And Employee Benefit Expense | 0.04 Cr | 28000.00 | -0.04 Cr | 0.07 Cr | — |
| Net Income From Continuing Operations | -1.80 Cr | -1.54 Cr | -0.41 Cr | -2.12 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 0.01 Cr | — | 10.00 | — |
| Net PPE Purchase And Sale | — | — | — | — | 0.00 |
| Purchase Of PPE | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Brawn Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.